Skip to main content
. 2019 Jun 7;1(1):20180027. doi: 10.1259/bjro.20180027

Table 5.

Toxicities according CTCAE v4 (n = 42)

Number of patients Prostate with rectal spacer (n = 23) Prostate without rectal spacer (n = 10) Prostate bed (n = 9) Total (n = 42)
Acute urinary toxicity
All: Grade 1, Grade 2, Grade 3, > Grade 3
Cystitis Grade 1, Grade 2, Grade 3
Dysuria Grade 1, Grade 2
Others
14: 10, 3, 1, 0
13, 3, 1
4, 4
0
10: 6, 3, 0, 0
3, 1, 0
3, 3
0
4: 2, 3, 0, 0
2, 1, 0
0, 1
0
28 (64%)
21 (50%)
15 (36%)
0
Acute rectal toxicity
Diarrhea Grade 1 > Grade 1
Others
0, 0
0
2, 0
0
1, 0
0
3 (7%)
0
Late urinary toxicity
Cystitis Grade 1 Grade 2 > Grade 3
Dysuria Grade 1 > Grade 1
Urinary incontinence Grade 3
Others
2, 1, 0
3, 0
1
0
2, 0, 0
1, 0
0
0
1, 1, 0
0 0
0
0
7 (17%)
4 (9%)
1 (2%)
0
Acute rectal toxicity
Diarrhea Grade 1 > Grade 1
Others
0, 0
0
2, 0
0
1, 0
0
3 (7%)
0
Late rectal toxicity
All
0 0 0 0